BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8349291)

  • 1. Cognitive function at high altitude.
    Kramer AF; Coyne JT; Strayer DL
    Hum Factors; 1993 Jun; 35(2):329-44. PubMed ID: 8349291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive performance during a simulated climb of Mount Everest: implications for brain function and central adaptive processes under chronic hypoxic stress.
    Abraini JH; Bouquet C; Joulia F; Nicolas M; Kriem B
    Pflugers Arch; 1998 Jul; 436(4):553-9. PubMed ID: 9683728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude.
    Grissom CK; Richer LD; Elstad MR
    Chest; 2005 Feb; 127(2):565-70. PubMed ID: 15705997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a speed ascent to the top of Europe on cognitive function in elite climbers.
    Champigneulle B; Davranche K; Brugniaux JV; Baillieul S; Gajdos T; Doutreleau S; Robach P; Bouzat P; Verges S
    Eur J Appl Physiol; 2022 Mar; 122(3):635-649. PubMed ID: 34993575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Working Memory and Physiological Monitoring During a High-Altitude Expedition.
    Malle C; Ginon B; Bourrilhon C
    High Alt Med Biol; 2016 Dec; 17(4):359-364. PubMed ID: 27548274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive changes at high altitude in healthy climbers and in climbers developing acute mountain sickness.
    Regard M; Landis T; Casey J; Maggiorini M; Bärtsch P; Oelz O
    Aviat Space Environ Med; 1991 Apr; 62(4):291-5. PubMed ID: 2031628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mountaineering fatalities on Denali.
    McIntosh SE; Campbell AD; Dow J; Grissom CK
    High Alt Med Biol; 2008; 9(1):89-95. PubMed ID: 18331224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mount Everest: a space analogue for speech monitoring of cognitive deficits and stress.
    Lieberman P; Morey A; Hochstadt J; Larson M; Mather S
    Aviat Space Environ Med; 2005 Jun; 76(6 Suppl):B198-207. PubMed ID: 15943213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colour vision at very high altitude.
    Leid J; Campagne JM
    Color Res Appl; 2001; 26 Suppl 1():S281-3. PubMed ID: 12269339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mountaineering medical events and trauma on Denali, 1992-2011.
    McIntosh SE; Campbell A; Weber D; Dow J; Joy E; Grissom CK
    High Alt Med Biol; 2012 Dec; 13(4):275-80. PubMed ID: 23270445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced oxygen due to high-altitude exposure relates to atrophy in motor-function brain areas.
    Di Paola M; Bozzali M; Fadda L; Musicco M; Sabatini U; Caltagirone C
    Eur J Neurol; 2008 Oct; 15(10):1050-7. PubMed ID: 18717724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-altitude retinopathy after climbing Mount Aconcagua in a group of experienced climbers.
    Ho TY; Kao WF; Lee SM; Lin PK; Chen JJ; Liu JH
    Retina; 2011 Sep; 31(8):1650-5. PubMed ID: 21478809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m.
    Bloch KE; Turk AJ; Maggiorini M; Hess T; Merz T; Bosch MM; Barthelmes D; Hefti U; Pichler J; Senn O; Schoch OD
    High Alt Med Biol; 2009; 10(1):25-32. PubMed ID: 19326598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of High-Altitude Mountaineering on Cognitive Function in Mountaineers: A Meta-Analysis.
    Li L; Zhou Y; Zou S; Wang Y
    Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36982007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive performance in high-altitude climbers: a comparative study of saccadic eye movements and neuropsychological tests.
    Merz TM; Bosch MM; Barthelmes D; Pichler J; Hefti U; Schmitt KU; Bloch KE; Schoch OD; Hess T; Turk AJ; Schwarz U
    Eur J Appl Physiol; 2013 Aug; 113(8):2025-37. PubMed ID: 23563571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High altitude pulmonary edema in mountain climbers.
    Korzeniewski K; Nitsch-Osuch A; Guzek A; Juszczak D
    Respir Physiol Neurobiol; 2015 Apr; 209():33-8. PubMed ID: 25291181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroenteritis outbreak among mountaineers climbing the West Buttress route of Denali - Denali National Park, Alaska, June 2002.
    McLaughlin JB; Gessner BD; Bailey AM
    Wilderness Environ Med; 2005; 16(2):92-6. PubMed ID: 15974258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematological indices, mountain sickness and MRI brain abnormalities in professional and amateur mountain climbers after altitude exposure.
    Fayed N; Diaz L; Dávila J; Medrano J
    Neurol Res; 2010 Mar; 32(2):144-7. PubMed ID: 19422736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon monoxide exposure on Denali: comparing the 2004 and 2005 climbing seasons.
    Roscoe C; Baker E; Johnston E; Sandven T; Gustafson C; Arndt T; Dow J
    Wilderness Environ Med; 2008; 19(1):15-21. PubMed ID: 18333664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expertise effects on the perceptual and cognitive tasks of indoor rock climbing.
    Whitaker MM; Pointon GD; Tarampi MR; Rand KM
    Mem Cognit; 2020 Apr; 48(3):494-510. PubMed ID: 31667757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.